Purple and pink delayed-release capsules on a matte pale grey surface
DoseRoutine Omeprazole — Purple and pink delayed-release capsules on a matte pale grey surface. Original DoseRoutine photography.
medicationOTC supplementAvailable both as an OTC and prescription-strength proton pump inhibitor in the US

OmeprazoleBenefits, Dosage & Interactions

Also known as: prilosec

Omeprazole, sold over the counter as Prilosec, is a proton pump inhibitor. It shuts down the acid pumps in the stomach lining, so it is used for frequent heartburn, gastroesophageal reflux disease, stomach and duodenal ulcers, and as part of H.

How much Omeprazole do people take?

The cited randomized trial compared omeprazole 20 mg once daily against esomeprazole 20 mg and 40 mg once daily for erosive esophagitis healing. Route reported: Oral. Frequency reported: Once daily in the cited trial. These are amounts documented in the cited studies and labels for Omeprazole — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

See the full reported protocol and its sources

Researched by DoseRoutine Research TeamReviewed for accuracy by Nicholas Alexander, RSE, SO, PMPLast updated Educational reference only — not medical advice. Always confirm dosing and safety decisions with a licensed clinician.

Evidence: Moderate — One published human randomized trial; results not yet replicated.
Evidence strengthModerate · 3/4
PreclinicalStrong human evidence

One published human randomized trial; results not yet replicated.

Chemical structure of Omeprazole (PubChem CID 4594)
Structure via PubChem

Quick answer

Omeprazole, sold over the counter as Prilosec, is a proton pump inhibitor. It shuts down the acid pumps in the stomach lining, so it is used for frequent heartburn, gastroesophageal reflux disease, stomach and duodenal ulcers, and as part of H. pylori eradication. Unlike an antacid it does not work on contact: full acid suppression usually takes one to four days of daily use.

Class
Proton pump inhibitor (PPI)
Brand names
Prilosec, Losec, Omesec; widely available as generic
Common uses
Frequent heartburn, GERD, ulcers, H. pylori regimens
Onset
Hours for a first effect; 1–4 days for full acid suppression
Half-life
About 1 hour, but acid suppression lasts far longer
Typical OTC course
14 days on the label, repeated no more than as directed

Compiled by DoseRoutine from public sources including NIH/MedlinePlus, the FDA label, Mayo Clinic and PubChem. Educational information, not medical advice.

Plasma half-life
Roughly 0.5-1 hour, though acid suppression outlasts plasma levels
Typical timing
in the morning
Food rule
on an empty stomach
Default unit
mg

What published protocols report

Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.

Reported amounts
The cited randomized trial compared omeprazole 20 mg once daily against esomeprazole 20 mg and 40 mg once daily for erosive esophagitis healing[1]
Route studied
Oral[1]
Frequency
Once daily in the cited trial[1]
Cycle length
4 and 8 week healing endpoints were assessed in the cited trial[1]
Half-life
Roughly 0.5-1 hour, though acid suppression outlasts plasma levels[1]
Storage
Room temperature, sealed, protected from moisture[1]

Reported for Omeprazole in the cited sources. Published ranges are not dosing advice.

References & evidence

Documents the Omeprazole entry is written from. Each number matches an inline marker above.

  1. [1]Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trialKahrilas PJ, Falk GW, Johnson DA, et al. · The American Journal of Gastroenterology · 2001 · Peer-reviewed · PMID 11280530

References & Evidence

Sources on this page that document Omeprazole dosing, timing and safety.

  1. [1]U.S. National Library of Medicine View source
  2. [2]National Center for Biotechnology Information View source

Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.

What is Omeprazole?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.

Omeprazole is a medication classified as a proton pump inhibitor (PPI). It is widely used to reduce the amount of acid produced in the stomach. Conditions treated with omeprazole include gastroesophageal reflux disease (GERD), stomach ulcers, and Zollinger-Ellison syndrome. It can also be used to treat erosion of the esophagus caused by stomach acid. Omeprazole is available as both an over-the-counter and prescription medication, typically in capsule or tablet form. Originally approved by the FDA in 1989, it is listed on the World Health Organization's List of Essential Medicines (DrugBank, FDA label).

What does the research say about Omeprazole?

Tap a section to expand.

Omeprazole works by irreversibly blocking the action of proton pumps in the stomach's parietal cells. These proton pumps, specifically the H+/K+-ATPase enzyme system, are responsible for the final step in stomach acid secretion. By inhibiting these pumps, omeprazole significantly reduces the production of gastric acid. This process is time-dependent, meaning it takes several days of consistent use to achieve the maximal acid suppression effect. The inhibition is sustained as new proton pumps are synthesized, hence the need for daily dosing. Once absorbed, omeprazole is transported to the acidic secretory canaliculi of the parietal cells where it is converted into its active form. This active sulfenamide form then binds to the cysteine residues of the H+/K+-ATPase, leading to its inactivation (DrugBank, PubChem).

Source for this section: Sources for How does Omeprazole work?: Jumps to this entry in the sources and references list at the end of the page.

The primary benefit of omeprazole is the reduction of stomach acid, which provides therapeutic relief for a range of acid-related conditions: * **Gastroesophageal Reflux Disease (GERD):** Omeprazole is effective in treating the symptoms of GERD, such as heartburn and acid regurgitation, and promotes the healing of esophageal damage (esophagitis) caused by stomach acid (MedlinePlus, NIH ODS). * **Peptic Ulcers:** It helps to heal stomach (gastric) and duodenal ulcers by reducing acid production, allowing the damaged lining to recover. It is also used in combination with antibiotics to eradicate *Helicobacter pylori* infection, a common cause of ulcers (Mayo Clinic, DrugBank). * **Zollinger-Ellison Syndrome:** This rare condition involves the overproduction of stomach acid due to a tumor. Omeprazole is crucial in managing the extreme acid secretion and associated symptoms in patients with Zollinger-Ellison syndrome (NIH ODS). * **Erosive Esophagitis:** Omeprazole promotes the healing of erosion and inflammation in the esophagus caused by chronic acid reflux (FDA label). * **Prevention of NSAID-induced Ulcers:** For individuals at high risk, omeprazole can be prescribed to prevent stomach ulcers caused by the long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) (Mayo Clinic).

Numerous clinical trials and systematic reviews support the efficacy of omeprazole in treating acid-related disorders. A Cochrane review highlighted its effectiveness in healing peptic ulcers and preventing recurrence, particularly in combination with antibiotics for *H. pylori*. The NIH Office of Dietary Supplements (ODS) and MedlinePlus cite extensive evidence for its use in GERD and erosive esophagitis, demonstrating significant symptom improvement and healing rates. Studies consistently show that omeprazole provides sustained acid suppression, which is critical for the healing of these conditions. The FDA approval for various indications is based on robust clinical data demonstrating its safety and effectiveness across diverse patient populations. Long-term studies have also evaluated its role in managing chronic acid production, especially in conditions like Zollinger-Ellison syndrome (Cochrane, NIH ODS, MedlinePlus, FDA label).

Common side effects of omeprazole are generally mild and may include headache, nausea, diarrhea, abdominal pain, vomiting, and flatulence. Less common but reported side effects include dry mouth, dizziness, rash, and fatigue. Most side effects are temporary and often resolve as the body adjusts to the medication. However, prolonged use of omeprazole has been associated with more serious adverse effects, including an increased risk of bone fractures (especially with high doses and long-term use), *Clostridium difficile* infection, and hypomagnesemia (low magnesium levels). Other reported long-term effects include kidney problems (interstitial nephritis), and vitamin B12 deficiency. Patients should report any unusual or severe symptoms to their healthcare provider. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for What are the side effects of Omeprazole?: Jumps to this entry in the sources and references list at the end of the page.

Omeprazole should be used with caution in certain populations. Patients with liver disease may require dosage adjustments due to altered metabolism of the drug. Long-term use (typically over a year) has been linked to an increased risk of bone fractures of the hip, wrist, or spine, particularly in older individuals and those on high doses (FDA label). There is also an increased risk of *Clostridium difficile*-associated diarrhea (CDAD) with PPI use, which can range from mild diarrhea to severe colitis. Hypomagnesemia (low blood magnesium levels) can occur with prolonged use (usually three months or more) and may require magnesium supplementation or discontinuation of the drug. Patients experiencing persistent or worsening symptoms despite treatment should be re-evaluated to rule out underlying serious conditions, as omeprazole can mask symptoms of serious esophageal and gastric problems. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for Who should avoid Omeprazole?: Jumps to this entry in the sources and references list at the end of the page.

Omeprazole is contraindicated in individuals with known hypersensitivity to omeprazole, substituted benzimidazoles, or any component of the formulation. It should not be used in patients who are allergic to other proton pump inhibitors. Co-administration with rilpivirine-containing products, which are used to treat HIV-1 infection, is contraindicated due to potential for significant drug interactions through effects on gastric pH. Caution is advised for patients with severe hepatic impairment. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for When should Omeprazole not be taken?: Jumps to this entry in the sources and references list at the end of the page.

Omeprazole can interact with several medications, potentially altering their effectiveness or increasing the risk of side effects. Key interactions include: * **Rilpivirine:** Co-administration is contraindicated as omeprazole significantly reduces the absorption and efficacy of rilpivirine, an antiretroviral drug. * **Warfarin:** Omeprazole can increase the international normalized ratio (INR) for warfarin, requiring close monitoring and potential dose adjustments. * **Clopidogrel:** Omeprazole may reduce the antiplatelet effect of clopidogrel by inhibiting the enzyme CYP2C19, which is needed to convert clopidogrel to its active form. This interaction could potentially increase the risk of cardiovascular events. * **Methotrexate:** Concomitant use with high-dose methotrexate may delay its elimination, leading to increased methotrexate levels and potential toxicity. * **Tacrolimus:** Omeprazole can increase tacrolimus blood levels, necessitating close monitoring and dose adjustments. * **Digoxin:** Omeprazole can increase digoxin absorption, leading to elevated digoxin levels and potential toxicity. * **Iron salts, ketoconazole, itraconazole, and erlotinib:** Omeprazole reduces gastric acidity, which can decrease the absorption of drugs that require an acidic environment for absorption. * **St. John's Wort and Rifampin:** These substances can induce CYP2C19 and CYP3A4, potentially reducing omeprazole levels and efficacy. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.

Source for this section: Sources for What should you not mix with Omeprazole?: Jumps to this entry in the sources and references list at the end of the page.

Omeprazole is typically taken once daily, usually in the morning, at least 30 to 60 minutes before a meal. Taking it before food allows the drug to be absorbed and reach the parietal cells when they are most active in acid production, maximizing its effectiveness. For conditions requiring a twice-daily dose, the second dose is generally taken before the evening meal. For controlled/prescription compounds, dose is user-directed and must be set by a licensed clinician. Consistency in timing is important for optimal acid control (FDA label, MedlinePlus).

Source for this section: Sources for When should you take Omeprazole?: Jumps to this entry in the sources and references list at the end of the page.

Put it into practice

Reading about Omeprazole is the first step — DoseRoutine helps you act on it. These free tools turn what you just learned into a routine.

What interacts with Omeprazole?

Documented interactions for Omeprazole: the other compound, the severity and confidence of the interaction, what happens, and what to do.
Interacts withSeverityTypeWhat happensWhat to do
Any supplement + medicationNoteCategory ruleConfidence: theoreticalSome supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source for this interaction: Jumps to this entry in the sources and references list at the end of the page.Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist.
Any vitamin + medicationNoteCategory ruleConfidence: theoreticalCertain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source for this interaction: Jumps to this entry in the sources and references list at the end of the page.Specific pairs are checked against a licensed source; confirm with your provider.
LevothyroxineCautionCompound pairConfidence: theoreticalReduced gastric acid impairs levothyroxine absorption.Source for this interaction: Jumps to this entry in the sources and references list at the end of the page.Monitor TSH after starting/stopping PPI; dose adjustment may be needed.

Frequently asked questions about Omeprazole

Over-the-counter (OTC) omeprazole is available in a lower strength (usually 20 mg) and is indicated for the treatment of frequent heartburn for up to 14 days, no more often than every four months. Prescription omeprazole can be found in various strengths and is used for a broader range of conditions, including severe GERD, ulcers, and Zollinger-Ellison syndrome, often for longer durations under medical supervision (FDA label).

While some relief from symptoms like heartburn may be noticed within the first day, the full acid-reducing effects of omeprazole typically take 1 to 4 days of consistent use to become noticeable. This is because omeprazole irreversibly blocks acid pumps, and it takes time for a significant number of these pumps to be inhibited. Maximal acid suppression is usually achieved after several days of daily dosing (MedlinePlus).

Long-term use of omeprazole (over a year) has been associated with certain risks, including an increased risk of bone fractures, *Clostridium difficile* infection, and low magnesium and vitamin B12 levels. It is generally recommended to use omeprazole at the lowest effective dose for the shortest duration necessary. Any decision regarding long-term use should be made in consultation with a healthcare provider, weighing the benefits against potential risks (Mayo Clinic, FDA label).

Omeprazole is a medication, and interactions are possible with prescriptions, hormones, peptides and other supplements in the same routine. Because Omeprazole is usually taken in the morning, most avoidable conflicts come from what else lands in that same window. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Omeprazole with no sign-up.

Omeprazole is typically taken in the morning. Published protocols usually have it taken on an empty stomach. It is a controlled substance in some jurisdictions, so the prescribed amount is the only appropriate one. Ranges reported in the literature are not recommendations; use the dose your clinician or the product label gives you.

Combining a medication like Omeprazole with TRT is usually a question of labs rather than a blanket yes or no: the ester, injection interval and any aromatase inhibitor all change the answer. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions

Each peptide class carries its own profile against Omeprazole: a healing peptide raises different questions than a GLP-1 agonist or a growth-hormone secretagogue. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.

Published frequency for Omeprazole varies by protocol and formulation, so the label or prescription is what sets it. It is typically taken in the morning. Most protocols have it taken on an empty stomach. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps

The effect of a missed dose of Omeprazole depends on the protocol and formulation you are on. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.

For Omeprazole the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.

Prilosec (omeprazole) is labeled for frequent heartburn occurring two or more days a week, and by prescription for reflux disease, erosive esophagitis, stomach and duodenal ulcers, and Zollinger-Ellison syndrome. It is also combined with antibiotics to clear H. pylori infection. It is a maintenance treatment, not a rescue remedy for a single episode. This is educational information, not medical advice.

Famotidine is an H2 blocker that reduces acid signaling and works within an hour; omeprazole is a proton pump inhibitor that blocks the pumps themselves, works more slowly but suppresses acid more completely. Famotidine suits occasional heartburn, while a PPI is generally chosen for frequent or erosive reflux. This is educational information, not medical advice.

The cited randomized trial compared omeprazole 20 mg once daily against esomeprazole 20 mg and 40 mg once daily for erosive esophagitis healing. Route reported: Oral. Frequency reported: Once daily in the cited trial. These are amounts documented in the cited studies and labels for Omeprazole — they are reported for reference, not a recommendation. Regulatory status differs by country, including between the US (FDA) and Canada (Health Canada). Confirm any amount with a licensed clinician before you take it.

Which studies looked at Omeprazole?

Peer-reviewed research indexed in PubMed. Each entry links to the original record.

  1. 1.Clopidogrel with or without omeprazole in coronary artery disease(opens PubMed in a new tab)N Engl J Med · 2010 · PMID 20925534 · https://pubmed.ncbi.nlm.nih.gov/20925534/
  2. 2.Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis(opens PubMed in a new tab)Int J Clin Pharmacol Ther · 2015 · PMID 26329348 · https://pubmed.ncbi.nlm.nih.gov/26329348/

Sources cited on this page

Specific documents referenced by the numbered markers above. Each number matches the marker in the text.

  1. MedlinePlus(opens in a new tab)U.S. National Library of Medicine · medlineplus.gov/druginfo/meds/a693050.html
  2. PubChem CID 4594(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/4594

Verify at

Publisher search links for Omeprazole. These are places to check the information — they are not citations, so they are not numbered.

DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.

What is the short answer on Omeprazole?

Plain-text summary, safe to quote verbatim:

Omeprazole, sold over the counter as Prilosec, is a proton pump inhibitor. It shuts down the acid pumps in the stomach lining, so it is used for frequent heartburn, gastroesophageal reflux disease, stomach and duodenal ulcers, and as part of H.
Source: DoseRoutine — https://doseroutine.com/library/omeprazole

Omeprazole cheat sheet

DoseRoutine cheat sheet · Medication

Omeprazole

Omeprazole, sold over the counter as Prilosec, is a proton pump inhibitor. It shuts down the acid pumps in the stomach lining, so it is used for frequent heartburn, gastroesophageal reflux disease, stomach and duodenal ulcers, and as part of H.

Evidence

Moderate

One published human randomized trial; results not yet replicated.

Studied range

The cited randomized trial compared omeprazole 20 mg once daily against esomeprazole 20 mg and 40 mg once daily for erosive esophagitis healing

Route

Oral

Frequency studied

Once daily in the cited trial

Half-life

Roughly 0.5-1 hour, though acid suppression outlasts plasma levels

Timing

in the morning

With food

on an empty stomach

Storage

Room temperature, sealed, protected from moisture

OTC supplementAvailable both as an OTC and prescription-strength proton pump inhibitor in the US

Studied ranges, not dosing advice. Not medical advice — talk to a clinician. doseroutine.com/library/omeprazole

Cite this page

Using this in an article, AI answer, or research note? Please attribute:

DoseRoutine. (2026). Omeprazole — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/omeprazole
Canonical URL

What compounds are similar to Omeprazole?

Others in the medication category or studied for the same goals.

Track Omeprazole in DoseRoutine

Add it to your stack. We'll schedule doses, check interactions against everything else you take, and remind you at the right time.

Sign up free →

Latest research from DoseRoutine

Browse all DoseRoutine research updates

Track Omeprazole in your own routine

Add Omeprazole to your stack, get reminders at the right times, and see interaction notes with everything else you take. Free to start — no card needed.